Prelude Capital Management, LLC Siga Technologies Inc Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.93 - $5.8 $7,725 - $9,088	-1,567 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.22 - $6.1 $8,179 - $9,558	1,567 New	1,567 $9,000
Q1 2019 May 15, 2019	SELL	$5.66 - $7.89 $76,732 - $106,964	-13,557 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$4.77 - $7.9 $205 - $339	-43 Reduced 0.32%	13,557 $107,000
Q3 2018 Nov 14, 2018	BUY	$6.03 - $8.34 $82,008 - $113,424	13,600 New	13,600 $94,000
Q2 2018 Aug 14, 2018	SELL	$5.89 - $7.29 $50,065 - $61,965	-8,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.7 - $6.65 $39,950 - $56,525	8,500 New	8,500 $52,000

166

33.8M

353K

853K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $623M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.